Ogasawara et al., "Potentiation of Vincristine Cytotoxicity by Ruginone B1 and Piperasfizine A in Human Moser and K562 Cells-Mode of Action", J. Antibiotics, 45(1):129-132(1992). |
Murdock et al., "Antitumor Agents. 1.1,4-Bis[(aminoalky)amino]-9,10-anthracenediones", J. Medicinal Chemistry, 22(9):10214-1030(1979). |
ZEE-Cheng et al., "Antineoplastic Agents. Structure-Activity Relationship Study of Bis(substituted aminoalkylamino) Anthraquinones", J. Medicinal Chemsitry, 21(3):291-294(1978). |
International Search Report dated Mar. 17, 1995 for International Application No. PCT/US94/13235. |
Sachs, et al., "Protein Kinase C (PKC) Inhibitors Increase Drug Accumulation and are Cytotoxic to a Human Multidrug Resistant (MDR) Breast Cancer Line", Proc. Amer. Assoc. for Cancer Res., 31:359, Abstract 2128, 1990. |
Ballas, et al., "Mitoxantrone Inhibits Serine/Threonine Kineases Associated with Signal Transduction and Milogenesis", Proc. Amer. Assoc. Cancer Res., 32:394, Abstract 2344, 1991. |
Sachs, et al., "Protein Kinase C Inhibitors Increase Drug Accumulation and Decrease Resistance of Multidrug Resistant Cell Lines", Proc. Amer. Assoc. Cancer Res., 32:373, Abstract 2218, 1991. |
Fine, "Multidrug Resistance", Pinedo, et al., (eds) Cancer Chemotherapy and Biological Response Modifiers, pp. 73-84, NY; Elsevier Scientific Publishers, 1988. |
Ford, et al., "Pharmacology of Drugs that Alter Multidrug Resistance in Cancer", Pharmacological Reviews 42(3);155-199(1990). |
Bellamy, et al., "The Clinical Relevance of Multidrug Resistance", Cancer Investigation, 8(5):547-562(1990). |
Ford, et al., "Cellular and Bilchemical Characterization of Thioxanthenes for Reversal of Multidrug Resistance in Human and Murine Cell Lines", Cancer Res., 50:1748-1756(1990). |
Ford, et al., "Structural Features Determining Activity of Phenothiazines and Related Drugs for Inhibition of Cell Growth and Reversal of Multidrug Resistance", Molecular Pharmacology, 35:105-115(1988). |
Pearce, et al., "Essential Features of the P-glycoprotein Pharmacophore as Defined by a Series of Reserpine Analogs that Modulate Multidrug Resistance", Proc. Natl. Acad. Sci. USA, 86:5128-5132(1989). |
Zamora, et al., "Physical-Chemical Properties Shared by Compounds that Modulate Multidrug Resistance in Human Leukemic Cells", Molecular Pharmacology, 33:454-462(1988). |
Cornwall, et al., "Increased Vinblastine Binding to Membrane Vesicles from Multidrug-Resistant KB Cells", J. Biol. Chem. 261(17):7921-7928(1986). |
Cornwell, et al., "Certain Calcium Channel Blockers Bind Specifically to Multidrug-Resistant Human KB Carcinoma Membrane Vesicles and Inhibit Drug Binding to P-glycoprotein", J. Biol. Chem., 262(5):2166-2170(1987). |
Cornwell, et al., "Membrane Vesicles from Multidrug-Resistant Human Cancer Cells Contain a Specific 150-to 170-kDa Protein Detected by Photoaffinity Labeling", Proc. Natl. Acad. Sci. USA, 83:3847-3850(1986). |
Naito, et al., "ATP/Mg.sup.2+ -Dependent Binding of Vincristine to the Plasma Membrane of Multidrug-Resistant K562 Cells", J. Biol. Chem., 263(24):11887-11891(1988). |
Safa, et al., "Identification of the Multidrug Resistance-Related Membrane Glycoprotein as an Acceptor for Calcium Channel Blockers", J. Biol. Chem., 262(16):7864-7888(1987). |
Tamai, et al., "Competitive Interaction of Cyclosporins with the Vinca Alkaloid-Binding Site of P-glycoprotein in Multidrug-Resistant Cells", J. Biol. Chem., 265(27):16509-16513(1990). |
Center, et al., "Mechanisims Regulating Cell Resistance to Adrimycin", Ciochem. Pharma. 34(9):1471-1476(1985). |
Hamada, et al., "Phosphorylation of the M,170,000 to 180,000 Glycoprotein Specific to Multidrug-Resistant Tumor Cells: Effects of Verapamil, Thrfluoperazine, and Phorbot Esters", Cancer Research 47:2869-2865(1987). |
Meyers, "Protein Phosphorylation of Multidrug-Resistant Chinese Hamster Cells", Cancer Communications, 4(4):23.gtoreq.241(1989). |
Blobe, et al., "Selective Regulation of Expression of Protein Kinase C (PKC) Isoenzymes in Multidrug-Resistant MCF-7 Cells", J. Biol. Chem., 268(1):658-664(1993). |
Chambers, et al., "Protein Kinase C Phosphorylates P-glycoprotein in Multidrug Resistant Human KB Carcinoma Cells", J. Biol. Chem., 265(13):7679-7686(1990). |
Fine, et al., "Phorbol Esters Induce Multidrug Resistance in Human Breast Cancer Cells", Proc. Natl. Acad. Sci. USA, 85:582-586(1988). |
Fojo, et al., "Expression of a Multidrug-Resistance Gene in Human Tumors and Tissues", Proc. Natl. Acad. Sci. USA, 84:265-269(1987). |
Dalton, et al., "Drug-Resistance in Multiple Myeloma and Non-Hodgkins'a Lymphoma: Detection of P-Glycoprotein and Potential Circumvention by Addition of Verspamil toChemotherapy", J. Clin. Oncology, 7(4):415-424(1989). |
Ozols, et al., "Verapamil and Adriamycin in the treatment of Drug-Resistant Ovarian Cancer Patients", J. Clin. Oncology, 5(4)641-647(1987). |